This activity is expired and is no longer available for CME credit.


Deciding Factors: Answering the Questions of When, How, and Why When Individualizing Multiple Sclerosis Treatment

Author(s)/Faculty: Fred D. Lublin, MD; Bruce A. Cohen, MD; Patricia K. Coyle, MD, FAAN
Release Date: 7/16/2015Expiration Date: 6/14/2017
Credit Type: CME / CNENumber of Credits: 0
Content Type: LectureProvider:
With an increasing range of disease-modifying treatment options for the management of multiple sclerosis, understanding how to initiate therapy and the relative strengths of different agents is critical in order to maximize patient outcomes and quality of life. Patient responses to a given therapy will vary, and some patients will stop responding to an agent over time, forcing clinicians to consider switching treatment regimens. There are limited data on the optimal switch strategies, so clinicians must consider the agents and the data that are available as well as use their clinical judgment to make informed recommendations to patients. Research continues, and new classes of agents are in development that could further improve patient outcomes in the years ahead. In this activity, leading clinicians will discuss strategies to initiate and switch therapy as well as review the early clinical trial results for several therapies.